Skip to main content
SpringerLink
Log in

Can pravastatin lower coronary event rate if HDL and LDL cholesterol are at low levels?

  • Practice Point
  • Published:

From Nature Clinical Practice Cardiovascular Medicine

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Grundy SM et al. (2004) Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel Guidelines. Circulation 110: 227–239

    Article  Google Scholar 

  2. Fodor JC et al. (2000) Recommendations for the management and treatment of dyslipidemia: report of the working group on hypercholesterolemia and other dyslipidemias. CMAJ 162: 1441–1447

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Sacks FM and Expert Group on HDL Cholesterol (2002) The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: expert group recommendations. Am J Cardiol 90: 139–143

  4. De Backer G et al. (2003) European guidelines on cardiovascular disease prevention: Third Joint Task Force of European and other societies on cardiovascular disease prevention in clinical practice. Eur Heart J 24: 1601–1610

    Article  Google Scholar 

  5. Rubins et al. (1999) Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 341: 410–418

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Hannah Camm, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. the Director of the Kim Dayani Center for Health Promotion at Vanderbilt University, Nashville, TN, USA

    David J Maron

Authors
  1. David J Maron
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David J Maron.

Ethics declarations

Competing interests

DJ Maron has received grant support from Kos Pharmaceuticals Inc., Merck & Co. Inc., Novartis Pharmaceuticals and Pfizer Inc.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maron, D. Can pravastatin lower coronary event rate if HDL and LDL cholesterol are at low levels?. Nat Rev Cardiol 1, 18–19 (2004). https://doi.org/10.1038/ncpcardio0006

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0006

  • Springer Nature Limited

Search

Navigation